Annals for Hospitalists – March 2024 | Annals of Internal Medicine
Can’t sign in? Forgot your password? If the address matches an exis ting account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Ann Intern Med. 2024;177:343-352. Published 27 February 2024. doi:10.7326/M23-2593 The ACTT-2 (Adaptive COVID-19 Treatment Trial-2) was a randomized controlled trial that investigated the use of baricitinib for treating hospitalized patients with COVID-19. That trial showed that baricitinib plus remdesivir improved